The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Efficacy of Antiretroviral Therapy Programs in Resource‐Poor Settings: A Meta‐analysis of the Published Literature
Abstract
BACKGROUND: Despite the advent of effective combination antiretroviral drug therapy (ART) for the treatment of human immunodeficiency virus (HIV) infection, many doubt the feasibility of ART treatment programs in resource-poor settings. We performed a meta-analysis of the efficacy of ART programs in the developing world. We searched the Medline database with the index terms "HIV," "antiretroviral therapy," "CD4 count," "viral load," "experience," and "outcomes." A total of 201 abstracts were reviewed, and 25 articles were selected for detailed review. Ten observational studies with details on patient outcomes were ultimately included in the analysis. METHODS: Three readers independently extracted data from the articles. The details recorded included patient demographic characteristics, baseline CD4 cell counts, baseline HIV RNA viral loads, ART histories, outcomes, and timing of the outcome measure. RESULTS: The proportion of subjects with an undetectable HIV viral load provided the measure of treatment efficacy. A random-effects model weighted the proportion of patients with undetectable viral load at various time points during ART. The proportion was 0.697 (95% CI, 0.582-0.812) at month 6 and 0.573 (95% CI, 0.432-0.715) at month 12 of ART. The provision of medications free of charge to the patient was associated with a 29%-31% higher probability of having an undetectable viral load at months 6 and 12 than was the requirement that patients pay part or all of the cost of therapy. CONCLUSIONS: ART treatment programs in resource-poor settings have efficacy rates similar to those reported for developed countries. The provision of medications free of charge to the patient is associated with a significantly increased probability of virologic suppression at months 6 and 12 of ART.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., Monforte, A. D., de Wolf, F., Reiss, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09411-4 · Cited by 1,525
Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412501 · Cited by 993
Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection
Walmsley, S., Bernstein, B., King, M., Arribas, J., Beall, G., Ruane, P., Johnson, M., Johnson, D., Lalonde, R., Japour, A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012354 · Cited by 647
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
Coetzee, D., Hildebrand, K., Boulle, A., Maartens, G., Louis, F., Labatala, V., Reuter, H., Ntwana, N., & Goemaere, E. (2004) · AIDS · doi:10.1097/00002030-200404090-00006 · Cited by 584
Bartlett, J. A., DeMasi, R., Quinn, J., Moxham, C., & Rousseau, F. (2001) · AIDS · doi:10.1097/00002030-200107270-00006 · Cited by 383
Adherence is not a barrier to successful antiretroviral therapy in South Africa
Orrell, C., Bangsberg, D. R., Badri, M., & Wood, R. (2003) · AIDS · doi:10.1097/00002030-200306130-00011 · Cited by 341
Weidle, P. J., Malamba, S., Mwebaze, R., Sozi, C., Rukundo, G., Downing, R., Hanson, D., Ochola, D., Mugyenyi, P., Mermin, J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09330-3 · Cited by 315
Laurent, C., Kouanfack, C., Koulla-Shiro, S., Nkoué, N., Bourgeois, A., Calmy, A., Lactuock, B., Nzeusseu, V., Mougnutou, R., Peytavin, G., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16586-0 · Cited by 309
Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., & Bangsberg, D. R. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408150-00014 · Cited by 282
Laurent, C., Diakhaté, N., Fatou Ngom Gueye, N., Awa Touré, M., Salif Sow, P., Awa Faye, M., Gueye, M., Lanièce, I., Touré Kane, C., Liégeois, F., et al. (2002) · AIDS · doi:10.1097/00002030-200207050-00008 · Cited by 272
Preventing antiretroviral anarchy in sub-Saharan Africa
Harries, A., Nyangulu, D., Hargreaves, N., Kaluwa, O., & Salaniponi, F. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05551-9 · Cited by 262
Hiv, G. B. C. O. (2005) · UNAIDS eBooks · Cited by 236
Farmer, P. E., Leandre, F., Mukherjee, J. S., Gupta, R., Tarter, L. L., & Kim, J. Y. (2001) · Europe PMC (PubMed Central) · Cited by 230
Stone, V. E., Jordan, J., Tolson, J., Miller, R., & Pilon, T. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200407010-00007 · Cited by 163
Moore, A. L., Kirk, O., Johnson, A. M., Katlama, C., Blaxhult, A., Dietrich, M., Colebunders, R., Chiesi, A., Lungren, J. D., & Phillips, A. N. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200304010-00017 · Cited by 148
Djomand, G., Roels, T. H., Ellerbrock, T. V., Hanson, D. L., Diomandé, F. V. K., Monga, B., Maurice, C., Nkengasong, J. N., Konan-Koko, R., Kadio, A., et al. (2003) · AIDS · doi:10.1097/00002030-200317003-00002 · Cited by 143
Virological response to protease inhibitor therapy in an HIV clinic cohort
Staszewski, S., Miller, V., Sabin, C. A., Carlebach, A., Berger, A.-M., Weidmann, E., Helm, E. B., Hill, A. D., & Phillips, A. N. (1999) · AIDS · doi:10.1097/00002030-199902250-00009 · Cited by 116
Defining and refining international donor support for combating the AIDS pandemic
Attaran, A., & Sachs, J. D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03576-5 · Cited by 114
Valdez, H., Lederman, M. M., Woolley, I. J., Walker, C. J., Vernon, L. T., Hise, A. G., & Gripshover, B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.15.1771 · Cited by 85
Tackling HIV in resource poor countries
Mukherjee, J. S., Farmer, P. E., Niyizonkiza, D., McCorkle, L., Vanderwarker, C., Teixeira, P., & Kim, J. (2003) · BMJ · doi:10.1136/bmj.327.7423.1104 · Cited by 73
Macharia, D. K., Chang, L. W., Lule, G., Owili, D. M., Tesfaledet, G., Patel, S. K., Silverstein, D. M., Nganga, L., Bush, T. J., Cock, K. M. D., et al. (2003) · AIDS · doi:10.1097/00002030-200304110-00028 · Cited by 20
Cited by
Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
Rosen, S., Fox, M. P., & Gill, C. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040298 · Cited by 796
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Anglaret, X., Myer, L., & Wood, R. (2008) · AIDS · doi:10.1097/qad.0b013e32830007cd · Cited by 639
The Survival Benefits of AIDS Treatment in the United States
Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., Weinstein, M. C., & Freedberg, K. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/505147 · Cited by 581
Fox, M. P., & Rosen, S. (2010) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02508.x · Cited by 559
Metadata
- Authors
- Ivers, L. C., Kendrick, D., & Doucette, K.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-15
- Volume
- 41
- Issue
- 2
- Pages
- 217-224
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2172274075
- Cited by
- 312
- References
- 24
- FWCI
- 19.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.